- Home
- TACH vs AUTL Comparison
TACH vs AUTL Comparison
Compare TACH & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACH
- AUTL
- Stock Information
- Founded
- TACH 2024
- AUTL 2014
- Country
- TACH United States
- AUTL United Kingdom
- Employees
- TACH N/A
- AUTL N/A
- Industry
- TACH
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TACH
- AUTL Health Care
- Exchange
- TACH Nasdaq
- AUTL Nasdaq
- Market Cap
- TACH 349.1M
- AUTL 415.2M
- IPO Year
- TACH 2025
- AUTL 2018
- Fundamental
- Price
- TACH $10.15
- AUTL $1.51
- Analyst Decision
- TACH
- AUTL Strong Buy
- Analyst Count
- TACH 0
- AUTL 5
- Target Price
- TACH N/A
- AUTL $9.12
- AVG Volume (30 Days)
- TACH 92.7K
- AUTL 4.6M
- Earning Date
- TACH 01-01-0001
- AUTL 11-11-2025
- Dividend Yield
- TACH N/A
- AUTL N/A
- EPS Growth
- TACH N/A
- AUTL N/A
- EPS
- TACH 0.19
- AUTL N/A
- Revenue
- TACH N/A
- AUTL $29,934,000.00
- Revenue This Year
- TACH N/A
- AUTL $641.63
- Revenue Next Year
- TACH N/A
- AUTL $109.21
- P/E Ratio
- TACH $53.19
- AUTL N/A
- Revenue Growth
- TACH N/A
- AUTL 185.17
- 52 Week Low
- TACH $10.00
- AUTL $1.11
- 52 Week High
- TACH $10.38
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- TACH N/A
- AUTL 46.20
- Support Level
- TACH N/A
- AUTL $1.56
- Resistance Level
- TACH N/A
- AUTL $1.65
- Average True Range (ATR)
- TACH 0.00
- AUTL 0.10
- MACD
- TACH 0.00
- AUTL 0.03
- Stochastic Oscillator
- TACH 0.00
- AUTL 54.84
About TACH Titan Acquisition Corp. Class A Ordinary Shares
Titan Acquisition Corp is a blank check company.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.